BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 10189388)

  • 1. Randomized prospective study comparing cost-effectiveness of teicoplanin and vancomycin as second-line empiric therapy for infection in neutropenic patients.
    Vázquez L; Encinas MP; Morín LS; Vilches P; Gutiérrez N; García-Sanz R; Caballero D; Hurlé AD
    Haematologica; 1999 Mar; 84(3):231-6. PubMed ID: 10189388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of febrile episodes in neutropenic leukemic patients with the antibiotic combinations piperacillin or ceftazidime plus amikacin: results of a randomized study.
    Fenu S; Raccah R; Santilli S; Micozzi A; Girmena C; Martino P; Avvisati G
    Chemioterapia; 1988 Oct; 7(5):323-6. PubMed ID: 3066517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Value of the combination of piperacillin and pefloxacin possibly followed by vancomycin in the treatment of febrile neutropenia in nephrotoxic chemotherapy].
    Kattan J; Droz JP; Culine S; Ribrag V; Boutan-Laroze A; Andremont A
    Bull Cancer; 1992; 79(7):705-12. PubMed ID: 1467596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Piperacillin plus amikacin versus cefotaxime plus amikacin in neutropenic and feverish patients with malignant hemopathies.
    Pavone V; Specchia G; Guarini A; Coniglio M; Iaculli L; Girardi F; Colucci A; Liso V
    Chemioterapia; 1988 Oct; 7(5):330-5. PubMed ID: 3224402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The use of teicoplanin in neutropenic patients: values and limits].
    Espinouse D; Chomarat M
    Pathol Biol (Paris); 1990 Jun; 38(5 ( Pt 2)):552-6. PubMed ID: 2143573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Evaluation of three types of empirical antibiotherapy in patients with febrile neutropenia: imipenem-cilastatin versus ceftazidime-vancomycin versus ticarcillin-amikacin-vancomycin].
    Bosseray A; Nicolini F; Brion JP; Michallet M; Hollard D; Stahl JP; Micoud M
    Pathol Biol (Paris); 1992 Oct; 40(8):797-804. PubMed ID: 1484739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Double-blind comparison of teicoplanin versus vancomycin in febrile neutropenic patients receiving concomitant tobramycin and piperacillin: effect on cyclosporin A-associated nephrotoxicity.
    Kureishi A; Jewesson PJ; Rubinger M; Cole CD; Reece DE; Phillips GL; Smith JA; Chow AW
    Antimicrob Agents Chemother; 1991 Nov; 35(11):2246-52. PubMed ID: 1839490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A prospective study comparing vancomycin and teicoplanin as second-line empiric therapy for infection in neutropenic patients.
    Cony-Makhoul P; Brossard G; Marit G; Pellegrin JL; Texier-Maugein J; Reiffers J
    Br J Haematol; 1990 Dec; 76 Suppl 2():35-40. PubMed ID: 2149050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Empirical treatment of febrile episodes in granulocytopenic patients with a combination of piperacillin and ofloxacin. Preliminary study].
    Raffi F; Feve B; Tiab M; Brisseau JM; Reynaud AE; Grolleau JY
    Pathol Biol (Paris); 1990 Jun; 38(5 ( Pt 2)):548-51. PubMed ID: 2385453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Piperacillin plus amikacin vs. piperacillin plus amikacin plus teicoplanin for empirical treatment of febrile episodes in neutropenic patients receiving quinolone prophylaxis.
    Martino P; Micozzi A; Gentile G; Raccah R; Girmenia C; Mandelli F
    Clin Infect Dis; 1992 Aug; 15(2):290-4. PubMed ID: 1387806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Piperacillin and amikacin in the treatment of infections in neoplasm patients with granulocytopenia].
    Giaccone G; Bagatella M; Donadio M; Bonardi GM; Calciati A
    Clin Ter; 1989 Aug 15-31; 130(3-4):191-5. PubMed ID: 2529094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Piperacillin and gentamicin as non toxic empirical therapy in pediatric patients with fever and neutropenia.
    González M; Clavell LA
    P R Health Sci J; 1987 Apr; 6(1):13-5. PubMed ID: 3615796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination and single-agent empirical antibacterial therapy for febrile cancer patients with neutropenia and mucositis.
    Shenep JL
    NCI Monogr; 1990; (9):117-22. PubMed ID: 2342588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prospective and comparative study of 2 antibiotic therapy protocols in 66 febrile neutropenic patients. Ceftazidime-vancomycin versus ticarcillin-vancomycin-amikacin].
    Brion JP; Bru JP; Michallet M; Corron B; Fauconnier J
    Presse Med; 1988 Oct; 17(37):1964-7. PubMed ID: 2973597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized study of teicoplanin plus ciprofloxacin versus gentamicin plus piperacillin for the empirical treatment of fever in neutropenic patients.
    Kelsey SM; Collins PW; Delord C; Weinhard B; Newland AC
    Br J Haematol; 1990 Dec; 76 Suppl 2():10-3. PubMed ID: 2149044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of two antibiotic regimens (piperacillin plus amikacin versus ceftazidime plus amikacin) as empiric therapy for febrile neutropenic patients with cancer.
    Feliu J; Artal A; González Barón M; Berrocal A; Chacón I; García de Paredes ML; Espinosa E; Ordóñez A; Zamora P; Montero JM
    Antimicrob Agents Chemother; 1992 Dec; 36(12):2816-20. PubMed ID: 1482151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic broad-spectrum antimicrobial prophylaxis in hematological patients after intensive antineoplastic chemotherapy.
    Verlicchi F; Ricci P; Bassi A; Benfenati D; Bandini G; Rosti G; Calori E; Borghi C; Tura S
    Haematologica; 1990; 75(1):91-3. PubMed ID: 2338294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Teicoplanin in the treatment of gram-positive bacteraemia in neutropenic patients.
    Micozzi A; Venditti M; Amadori S; Pulsoni A; Tirindelli C; Martino P
    Br J Haematol; 1990 Dec; 76 Suppl 2():19-23. PubMed ID: 2149046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ceftazidime plus amikacin versus ceftazidime plus vancomycin as empiric therapy in febrile neutropenic children with cancer.
    Viscoli C; Moroni C; Boni L; Bruzzi P; Comelli A; Dini G; Fabbri A; Secondo V; Terragna A
    Rev Infect Dis; 1991; 13(3):397-404. PubMed ID: 1866542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost comparison of seven antibiotic combinations as empiric therapy in a simulated febrile neutropenic patient.
    Parr MD; Waite WW; Hansen LA; McDaniel PA
    Am J Hosp Pharm; 1985 Nov; 42(11):2484-8. PubMed ID: 4073066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.